Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
NMTC 
Neuroone Medical Technologies Corp (NMTC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/05/2025: NMTC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $2.23
1 Year Target Price $2.23
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -46.06% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/05/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 33.89M USD | Price to earnings Ratio - | 1Y Target Price 2.23 |
Price to earnings Ratio - | 1Y Target Price 2.23 | ||
Volume (30-day avg) 1 | Beta 0.68 | 52 Weeks Range 0.40 - 1.39 | Updated Date 11/13/2025 |
52 Weeks Range 0.40 - 1.39 | Updated Date 11/13/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.16 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -80.5% | Operating Margin (TTM) -111.24% |
Management Effectiveness
Return on Assets (TTM) -45.07% | Return on Equity (TTM) -95.39% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 27855691 | Price to Sales(TTM) 5.37 |
Enterprise Value 27855691 | Price to Sales(TTM) 5.37 | ||
Enterprise Value to Revenue 4.2 | Enterprise Value to EBITDA -2.1 | Shares Outstanding 49999519 | Shares Floating 43619580 |
Shares Outstanding 49999519 | Shares Floating 43619580 | ||
Percent Insiders 11.71 | Percent Institutions 34.73 |
Upturn AI SWOT
Neuroone Medical Technologies Corp
Company Overview
History and Background
Neuroone Medical Technologies Corp. is focused on developing minimally invasive neuro-monitoring and therapeutic solutions. Founded relatively recently, it aims to improve outcomes for patients with neurological disorders through innovative technology.
Core Business Areas
- Neural Monitoring Systems: Development and commercialization of devices for real-time monitoring of brain activity, aiding in diagnosis and treatment of neurological conditions.
- Therapeutic Devices: Focus on creating minimally invasive therapeutic devices targeting specific neurological disorders.
Leadership and Structure
Information regarding leadership team and organizational structure is not readily available.
Top Products and Market Share
Key Offerings
- Evo Cortical Electrode: Minimally invasive electrode for recording brain activity. Limited market share information is publicly available. Competitors include Ad-Tech Medical Instrument Corp. and PMT Corporation.
Market Dynamics
Industry Overview
The neuromonitoring and neurotherapy market is experiencing growth driven by aging populations, increasing prevalence of neurological disorders, and advancements in neurotechnology.
Positioning
Neuroone is positioned as an innovator in minimally invasive neuro-monitoring. Competitive advantages lie in its proprietary technology and focus on less invasive procedures.
Total Addressable Market (TAM)
The global neuromonitoring market is estimated in the billions. Neuroone is positioned to capture a portion of this TAM through its innovative products.
Upturn SWOT Analysis
Strengths
- Innovative technology
- Minimally invasive approach
- Potential for improved patient outcomes
Weaknesses
- Limited commercialization experience
- Small market share
- Dependence on key personnel
- High research and development expenditure
Opportunities
- Expanding neuromonitoring market
- Partnerships with hospitals and research institutions
- New product development
- Regulatory approvals for existing products
Threats
- Competition from established players
- Regulatory hurdles
- Technological obsolescence
- Product liability risks
Competitors and Market Share
Key Competitors
- ADTM
- PMT
Competitive Landscape
Neuroone is a smaller player competing with larger, more established companies. Its advantage lies in its innovative technology, but it needs to scale up its commercial operations to gain a significant market share.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends are difficult to assess due to limited financial information.
Future Projections: Future growth is dependent on successful commercialization of its products and market adoption.
Recent Initiatives: Recent initiatives include further development of its Evo Cortical Electrode and exploring partnerships for commercialization.
Summary
Neuroone Medical Technologies Corp is a developing company in the neuromonitoring field with innovative, minimally invasive technology. Its strength is its product differentiation, however, it faces significant challenges in commercialization and competition. The company needs to establish key partnerships and secure regulatory approvals to achieve its growth potential. Lack of readily available financial data makes in-depth analysis challenging, which raises concerns.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Public Filings
Disclaimers:
This analysis is based on publicly available information and should not be considered financial advice. The information may not be complete or accurate, and is subject to change without notice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Neuroone Medical Technologies Corp
Exchange NASDAQ | Headquaters Eden Prairie, MN, United States | ||
IPO Launch date 2017-09-18 | President, CEO & Director Mr. David A. Rosa M.D. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 17 | Website https://nmtc1.com |
Full time employees 17 | Website https://nmtc1.com | ||
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, radio frequency and brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company also focuses on applications of its technology associated with artificial intelligence. It has partnership with RBC Medical Innovations to develop a radio frequency ablation generator. NeuroOne Medical Technologies Corporation is based in Eden Prairie, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.